Clinical Trial Update: A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas [Phase 2]

View source ↗

Summary

Results from a Phase II randomized trial in adults with recurrent high-grade gliomas comparing vandetanib with carboplatin followed by vandetanib versus carbopl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligoastrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Caprelsa (vandetanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Glioblastoma Multiforme, Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2016-03-29